Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuele Bizzi

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Internal and Emergency Medicine|February 26, 2024
Exploring IL-1 inhibition in chronic refractory idiopathic myocarditis: emerging insights and perspectivesMaddalena Alessandra Wu, Emanuele Bizzi, Antonio Brucato
European Journal of Internal Medicine|July 28, 2023
Inflammatory puzzle: Unveiling the role of D-Dimer in acute pericarditis and thromboinflammationMaddalena Alessandra Wu, Emanuele Bizzi, Antonio Brucato
Clinical Rheumatology|October 19, 2011
Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparatorAlberto Migliore, Emanuele Bizzi, Serena Broccoli, et al.
Clinical Rheumatology|June 25, 2011
Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparatorAlberto Migliore, Emanuele Bizzi, Serena Broccoli, et al.
Medical Hypotheses|July 21, 2015
Is it the time to rethink clinical decision-making strategies? From a single clinical outcome evaluation to a Clinical Multi-criteria Decision Assessment (CMDA)Alberto Migliore, Davide Integlia, Emanuele Bizzi, et al.
BMC Musculoskeletal Disorders|February 25, 2016
A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis ("Joint")Luis Severino Martin Martin, Umberto Massafra, Emanuele Bizzi, et al.
European Journal of Internal Medicine|September 24, 2021
Recent advances in pericarditisEmanuele Bizzi, Chiara Picchi, Greta Mastrangelo, et al.
Therapeutics and Clinical Risk Management|September 15, 2015
Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysisAlberto Migliore, Emanuele Bizzi, Colin Gerard Egan, et al.
Internal and Emergency Medicine|November 18, 2025
Experiences of omalizumab treatment in peritoneal dialysis and kidney and liver transplantationEmanuele Bizzi, Federica Samartin, Valentina Popescu Janu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2016
The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic AgentsAlberto Migliore, Emanuele Bizzi, Lea Petrella, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Internal and Emergency Medicine|February 26, 2024
Exploring IL-1 inhibition in chronic refractory idiopathic myocarditis: emerging insights and perspectivesMaddalena Alessandra Wu, Emanuele Bizzi, Antonio Brucato
European Journal of Internal Medicine|July 28, 2023
Inflammatory puzzle: Unveiling the role of D-Dimer in acute pericarditis and thromboinflammationMaddalena Alessandra Wu, Emanuele Bizzi, Antonio Brucato
Clinical Rheumatology|October 19, 2011
Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparatorAlberto Migliore, Emanuele Bizzi, Serena Broccoli, et al.
Clinical Rheumatology|June 25, 2011
Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparatorAlberto Migliore, Emanuele Bizzi, Serena Broccoli, et al.
Medical Hypotheses|July 21, 2015
Is it the time to rethink clinical decision-making strategies? From a single clinical outcome evaluation to a Clinical Multi-criteria Decision Assessment (CMDA)Alberto Migliore, Davide Integlia, Emanuele Bizzi, et al.
BMC Musculoskeletal Disorders|February 25, 2016
A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis ("Joint")Luis Severino Martin Martin, Umberto Massafra, Emanuele Bizzi, et al.
European Journal of Internal Medicine|September 24, 2021
Recent advances in pericarditisEmanuele Bizzi, Chiara Picchi, Greta Mastrangelo, et al.
Therapeutics and Clinical Risk Management|September 15, 2015
Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysisAlberto Migliore, Emanuele Bizzi, Colin Gerard Egan, et al.
Internal and Emergency Medicine|November 18, 2025
Experiences of omalizumab treatment in peritoneal dialysis and kidney and liver transplantationEmanuele Bizzi, Federica Samartin, Valentina Popescu Janu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 25, 2016
The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic AgentsAlberto Migliore, Emanuele Bizzi, Lea Petrella, et al.
Pageof 6